GENESIS: Potency-Graded Contrastive Learning for Generative Molecular Design and Drug Repurposing in Oral Squamous Cell Carcinoma

Computational drug discovery typically binarizes bioactivity, discarding the graded doseresponse signal needed for lead prioritization. We introduce Potency-Graded Contrastive Learning (PGCL), projecting frozen molecular language-model embeddings into a 128dimensional space via an ordinal contrastive objective, six-tier negative taxonomy, and tier-margin ranking. Across three seeds, PGCL achieves Spearman ρ = 0.555 ± 0.003 for potency ordering and target-switch AUROC = 0.967, outperforming flat-contrastive and binaryclassification ablations and roughly doubling ECFP4 activity-cliff discrimination. Among six generative architectures, our reinforcement-learning method CRAVE (Contrastive Reward-Aligned VAE Exploration) significantly exceeds non-RL baselines on OSCC potency after Bonferroni correction (p = 0.016). The frozen model transfers to lung adenocarcinoma without retraining — strongly along the PI3K/AKT/mTOR axis (PIK3CA ρ=0.688, MTOR ρ=0.614, AKT1 ρ=0.583, EGFR ρ=0.561) but only modestly when pooled across all 16 LUAD-relevant targets (ρ=0.207, n=52,373). An integrated docking, ADMET, network-pharmacology, and leadoptimization pipeline screens 23,308 repurposing candidates, prioritizing 46 Tier-1 candidates, including 13 triple-validated elite compounds, with transparently reported safety pass rates (14.6%) traced to an EGFR/aniline training-corpus skew. The pipeline runs end-to-end on consumer-grade hardware, with code and protocols enabling transfer to other cancers.

Authors

Publication Details

Journal
ChemRxiv
Published
2026-11-20
DOI
https://doi.org/10.26434/chemrxiv.15012518/v1
Primary Topic
Computational Drug Discovery Methods
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

GENESIS: Potency-Graded Contrastive Learning for Generative Molecular Design and Drug Repurposing in Oral Squamous Cell Carcinoma

Saurabh Bundela
2 links
ChemRxiv
Computational Drug Discovery Methods
preprint

GENESIS: Potency-Graded Contrastive Learning for Generative Molecular Design and Drug Repurposing in Oral Squamous Cell Carcinoma

Saurabh Bundela
preprint en

Abstract

Computational drug discovery typically binarizes bioactivity, discarding the graded doseresponse signal needed for lead prioritization. We introduce Potency-Graded Contrastive Learning (PGCL), projecting frozen molecular language-model embeddings into a 128dimensional space via an ordinal contrastive objective, six-tier negative taxonomy, and tier-margin ranking. Across three seeds, PGCL achieves Spearman ρ = 0.555 ± 0.003 for potency ordering and target-switch AUROC = 0.967, outperforming flat-contrastive and binaryclassification ablations and roughly doubling ECFP4 activity-cliff discrimination. Among six generative architectures, our reinforcement-learning method CRAVE (Contrastive Reward-Aligned VAE Exploration) significantly exceeds non-RL baselines on OSCC potency after Bonferroni correction (p = 0.016). The frozen model transfers to lung adenocarcinoma without retraining — strongly along the PI3K/AKT/mTOR axis (PIK3CA ρ=0.688, MTOR ρ=0.614, AKT1 ρ=0.583, EGFR ρ=0.561) but only modestly when pooled across all 16 LUAD-relevant targets (ρ=0.207, n=52,373). An integrated docking, ADMET, network-pharmacology, and leadoptimization pipeline screens 23,308 repurposing candidates, prioritizing 46 Tier-1 candidates, including 13 triple-validated elite compounds, with transparently reported safety pass rates (14.6%) traced to an EGFR/aniline training-corpus skew. The pipeline runs end-to-end on consumer-grade hardware, with code and protocols enabling transfer to other cancers.

ChemRxiv
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
GENESIS: Potency-Graded Contrastive Learning for Generative Molecular Design and Drug Repurposing in Oral Squamous Cell Carcinoma — Saurabh Bundela · ChemRxiv (2026) | TGRS Research Map | TGRS